Technology
Health
Pharmaceutical

Kaleido Biosciences

$8.64
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.27 (3.23%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell KLDO and other stocks, options, ETFs, and crypto commission-free!

About KLDO

Kaleido Biosciences, Inc. is a healthcare company, which focuses on leveraging the potential of the microbiome organ to treat disease and improve human health. The company was founded by Geoffrey von Maltzahn and Noubar B. Read More Afeyan in 2015 and is headquartered in Lexington, MA.

Employees
Headquarters
Lexington, Massachusetts
Founded
2015
Market Cap
257.76M
Price-Earnings Ratio
Dividend Yield
Average Volume
93.30K
High Today
$8.76
Low Today
$8.50
Open Price
$8.50
Volume
46.51K
52 Week High
$19.00
52 Week Low
$6.23

Collections

Technology
Health
Pharmaceutical
Healthcare
2019 IPO
US
North America
Female CEOs

KLDO Earnings

-$1.56
-$1.26
-$0.97
-$0.67
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Oct 31, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.